Medical Devices & Consumables

Global Artemisinin Combination Therapy Market Insights, Forecast to 2030

Artemisinin Combination Therapy is recommended for thetreatment of P. falciparum malaria. Fast acting artemisinin-based compounds arecombined with a drug from a different class and artemisinin derivatives include dihydroartemisinin, artesunate and artemether.
Market Analysis and Insights: Global Artemisinin Combination Therapy Market
The global Artemisinin Combination Therapy market is projected to grow from US$ 376.4 million in 2024 to US$ 498.6 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period.
The US & Canada market for Artemisinin Combination Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Artemisinin Combination Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Artemisinin Combination Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Artemisinin Combination Therapy include KPC Pharmaceuticals, Shanghai Fosun Pharmaceutical Industrial Development, Sanofi, Desano Holdings, Calyx Chemicals and Pharmaceuticals, Mylan, Novartis, Denk Pharma and Hovid Berhad, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Artemisinin Combination Therapy is widely used in various fields, such as Hospital, Clinic and Other,, etc. Hospital provides greatest supports to the Artemisinin Combination Therapy industry development. In 2023, global % revenue of Artemisinin Combination Therapy went into Hospital filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Artemisinin Combination Therapy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Artemisinin Combination Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Artemisinin Combination Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Artemisinin Combination Therapy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Artemisinin Combination Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Artemisinin Combination Therapy revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
KPC Pharmaceuticals
Shanghai Fosun Pharmaceutical Industrial Development
Sanofi
Desano Holdings
Calyx Chemicals and Pharmaceuticals
Mylan
Novartis
Denk Pharma
Hovid Berhad
Ipca Laboratories
Cipla
Aspen Pharmacare Holdings
Ajanta Pharma
Guilin Pharmaceuticals
Segment by Type
Artemether+Lumefantrine
Artesunate+Amodiaquine
Dihydroartemisinin+Piperaquine
Artesunate+Mefloquine
Artesunate+Sulfadoxine-Pyrimethamine
Pyronaridine-Artesunate
Other
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Artemisinin Combination Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artemisinin Combination Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artemisinin Combination Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artemisinin Combination Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Artemether+Lumefantrine
1.2.3 Artesunate+Amodiaquine
1.2.4 Dihydroartemisinin+Piperaquine
1.2.5 Artesunate+Mefloquine
1.2.6 Artesunate+Sulfadoxine-Pyrimethamine
1.2.7 Pyronaridine-Artesunate
1.2.8 Other
1.3 Market by Application
1.3.1 Global Artemisinin Combination Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artemisinin Combination Therapy Market Perspective (2019-2030)
2.2 Global Artemisinin Combination Therapy Growth Trends by Region
2.2.1 Artemisinin Combination Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Artemisinin Combination Therapy Historic Market Size by Region (2019-2024)
2.2.3 Artemisinin Combination Therapy Forecasted Market Size by Region (2025-2030)
2.3 Artemisinin Combination Therapy Market Dynamics
2.3.1 Artemisinin Combination Therapy Industry Trends
2.3.2 Artemisinin Combination Therapy Market Drivers
2.3.3 Artemisinin Combination Therapy Market Challenges
2.3.4 Artemisinin Combination Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Artemisinin Combination Therapy by Players
3.1.1 Global Artemisinin Combination Therapy Revenue by Players (2019-2024)
3.1.2 Global Artemisinin Combination Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Artemisinin Combination Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Artemisinin Combination Therapy, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Artemisinin Combination Therapy Market Concentration Ratio
3.4.1 Global Artemisinin Combination Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artemisinin Combination Therapy Revenue in 2023
3.5 Global Key Players of Artemisinin Combination Therapy Head office and Area Served
3.6 Global Key Players of Artemisinin Combination Therapy, Product and Application
3.7 Global Key Players of Artemisinin Combination Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Artemisinin Combination Therapy Breakdown Data by Type
4.1 Global Artemisinin Combination Therapy Historic Market Size by Type (2019-2024)
4.2 Global Artemisinin Combination Therapy Forecasted Market Size by Type (2025-2030)
5 Artemisinin Combination Therapy Breakdown Data by Application
5.1 Global Artemisinin Combination Therapy Historic Market Size by Application (2019-2024)
5.2 Global Artemisinin Combination Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Artemisinin Combination Therapy Market Size (2019-2030)
6.2 North America Artemisinin Combination Therapy Market Size by Type
6.2.1 North America Artemisinin Combination Therapy Market Size by Type (2019-2024)
6.2.2 North America Artemisinin Combination Therapy Market Size by Type (2025-2030)
6.2.3 North America Artemisinin Combination Therapy Market Share by Type (2019-2030)
6.3 North America Artemisinin Combination Therapy Market Size by Application
6.3.1 North America Artemisinin Combination Therapy Market Size by Application (2019-2024)
6.3.2 North America Artemisinin Combination Therapy Market Size by Application (2025-2030)
6.3.3 North America Artemisinin Combination Therapy Market Share by Application (2019-2030)
6.4 North America Artemisinin Combination Therapy Market Size by Country
6.4.1 North America Artemisinin Combination Therapy Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Artemisinin Combination Therapy Market Size by Country (2019-2024)
6.4.3 North America Artemisinin Combination Therapy Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Artemisinin Combination Therapy Market Size (2019-2030)
7.2 Europe Artemisinin Combination Therapy Market Size by Type
7.2.1 Europe Artemisinin Combination Therapy Market Size by Type (2019-2024)
7.2.2 Europe Artemisinin Combination Therapy Market Size by Type (2025-2030)
7.2.3 Europe Artemisinin Combination Therapy Market Share by Type (2019-2030)
7.3 Europe Artemisinin Combination Therapy Market Size by Application
7.3.1 Europe Artemisinin Combination Therapy Market Size by Application (2019-2024)
7.3.2 Europe Artemisinin Combination Therapy Market Size by Application (2025-2030)
7.3.3 Europe Artemisinin Combination Therapy Market Share by Application (2019-2030)
7.4 Europe Artemisinin Combination Therapy Market Size by Country
7.4.1 Europe Artemisinin Combination Therapy Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Artemisinin Combination Therapy Market Size by Country (2019-2024)
7.4.3 Europe Artemisinin Combination Therapy Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Artemisinin Combination Therapy Market Size (2019-2030)
8.2 China Artemisinin Combination Therapy Market Size by Type
8.2.1 China Artemisinin Combination Therapy Market Size by Type (2019-2024)
8.2.2 China Artemisinin Combination Therapy Market Size by Type (2025-2030)
8.2.3 China Artemisinin Combination Therapy Market Share by Type (2019-2030)
8.3 China Artemisinin Combination Therapy Market Size by Application
8.3.1 China Artemisinin Combination Therapy Market Size by Application (2019-2024)
8.3.2 China Artemisinin Combination Therapy Market Size by Application (2025-2030)
8.3.3 China Artemisinin Combination Therapy Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Artemisinin Combination Therapy Market Size (2019-2030)
9.2 Asia Artemisinin Combination Therapy Market Size by Type
9.2.1 Asia Artemisinin Combination Therapy Market Size by Type (2019-2024)
9.2.2 Asia Artemisinin Combination Therapy Market Size by Type (2025-2030)
9.2.3 Asia Artemisinin Combination Therapy Market Share by Type (2019-2030)
9.3 Asia Artemisinin Combination Therapy Market Size by Application
9.3.1 Asia Artemisinin Combination Therapy Market Size by Application (2019-2024)
9.3.2 Asia Artemisinin Combination Therapy Market Size by Application (2025-2030)
9.3.3 Asia Artemisinin Combination Therapy Market Share by Application (2019-2030)
9.4 Asia Artemisinin Combination Therapy Market Size by Region
9.4.1 Asia Artemisinin Combination Therapy Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Artemisinin Combination Therapy Market Size by Region (2019-2024)
9.4.3 Asia Artemisinin Combination Therapy Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Artemisinin Combination Therapy Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Artemisinin Combination Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Artemisinin Combination Therapy Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Artemisinin Combination Therapy Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Artemisinin Combination Therapy Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Artemisinin Combination Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Artemisinin Combination Therapy Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Artemisinin Combination Therapy Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Artemisinin Combination Therapy Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Artemisinin Combination Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Artemisinin Combination Therapy Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Artemisinin Combination Therapy Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Artemisinin Combination Therapy Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 KPC Pharmaceuticals
11.1.1 KPC Pharmaceuticals Company Details
11.1.2 KPC Pharmaceuticals Business Overview
11.1.3 KPC Pharmaceuticals Artemisinin Combination Therapy Introduction
11.1.4 KPC Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2019-2024)
11.1.5 KPC Pharmaceuticals Recent Developments
11.2 Shanghai Fosun Pharmaceutical Industrial Development
11.2.1 Shanghai Fosun Pharmaceutical Industrial Development Company Details
11.2.2 Shanghai Fosun Pharmaceutical Industrial Development Business Overview
11.2.3 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Introduction
11.2.4 Shanghai Fosun Pharmaceutical Industrial Development Revenue in Artemisinin Combination Therapy Business (2019-2024)
11.2.5 Shanghai Fosun Pharmaceutical Industrial Development Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Artemisinin Combination Therapy Introduction
11.3.4 Sanofi Revenue in Artemisinin Combination Therapy Business (2019-2024)
11.3.5 Sanofi Recent Developments
11.4 Desano Holdings
11.4.1 Desano Holdings Company Details
11.4.2 Desano Holdings Business Overview
11.4.3 Desano Holdings Artemisinin Combination Therapy Introduction
11.4.4 Desano Holdings Revenue in Artemisinin Combination Therapy Business (2019-2024)
11.4.5 Desano Holdings Recent Developments
11.5 Calyx Chemicals and Pharmaceuticals
11.5.1 Calyx Chemicals and Pharmaceuticals Company Details
11.5.2 Calyx Chemicals and Pharmaceuticals Business Overview
11.5.3 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Introduction
11.5.4 Calyx Chemicals and Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2019-2024)
11.5.5 Calyx Chemicals and Pharmaceuticals Recent Developments
11.6 Mylan
11.6.1 Mylan Company Details
11.6.2 Mylan Business Overview
11.6.3 Mylan Artemisinin Combination Therapy Introduction
11.6.4 Mylan Revenue in Artemisinin Combination Therapy Business (2019-2024)
11.6.5 Mylan Recent Developments
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Artemisinin Combination Therapy Introduction
11.7.4 Novartis Revenue in Artemisinin Combination Therapy Business (2019-2024)
11.7.5 Novartis Recent Developments
11.8 Denk Pharma
11.8.1 Denk Pharma Company Details
11.8.2 Denk Pharma Business Overview
11.8.3 Denk Pharma Artemisinin Combination Therapy Introduction
11.8.4 Denk Pharma Revenue in Artemisinin Combination Therapy Business (2019-2024)
11.8.5 Denk Pharma Recent Developments
11.9 Hovid Berhad
11.9.1 Hovid Berhad Company Details
11.9.2 Hovid Berhad Business Overview
11.9.3 Hovid Berhad Artemisinin Combination Therapy Introduction
11.9.4 Hovid Berhad Revenue in Artemisinin Combination Therapy Business (2019-2024)
11.9.5 Hovid Berhad Recent Developments
11.10 Ipca Laboratories
11.10.1 Ipca Laboratories Company Details
11.10.2 Ipca Laboratories Business Overview
11.10.3 Ipca Laboratories Artemisinin Combination Therapy Introduction
11.10.4 Ipca Laboratories Revenue in Artemisinin Combination Therapy Business (2019-2024)
11.10.5 Ipca Laboratories Recent Developments
11.11 Cipla
11.11.1 Cipla Company Details
11.11.2 Cipla Business Overview
11.11.3 Cipla Artemisinin Combination Therapy Introduction
11.11.4 Cipla Revenue in Artemisinin Combination Therapy Business (2019-2024)
11.11.5 Cipla Recent Developments
11.12 Aspen Pharmacare Holdings
11.12.1 Aspen Pharmacare Holdings Company Details
11.12.2 Aspen Pharmacare Holdings Business Overview
11.12.3 Aspen Pharmacare Holdings Artemisinin Combination Therapy Introduction
11.12.4 Aspen Pharmacare Holdings Revenue in Artemisinin Combination Therapy Business (2019-2024)
11.12.5 Aspen Pharmacare Holdings Recent Developments
11.13 Ajanta Pharma
11.13.1 Ajanta Pharma Company Details
11.13.2 Ajanta Pharma Business Overview
11.13.3 Ajanta Pharma Artemisinin Combination Therapy Introduction
11.13.4 Ajanta Pharma Revenue in Artemisinin Combination Therapy Business (2019-2024)
11.13.5 Ajanta Pharma Recent Developments
11.14 Guilin Pharmaceuticals
11.14.1 Guilin Pharmaceuticals Company Details
11.14.2 Guilin Pharmaceuticals Business Overview
11.14.3 Guilin Pharmaceuticals Artemisinin Combination Therapy Introduction
11.14.4 Guilin Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2019-2024)
11.14.5 Guilin Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Artemisinin Combination Therapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Artemether+Lumefantrine
Table 3. Key Players of Artesunate+Amodiaquine
Table 4. Key Players of Dihydroartemisinin+Piperaquine
Table 5. Key Players of Artesunate+Mefloquine
Table 6. Key Players of Artesunate+Sulfadoxine-Pyrimethamine
Table 7. Key Players of Pyronaridine-Artesunate
Table 8. Key Players of Other
Table 9. Global Artemisinin Combination Therapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 10. Global Artemisinin Combination Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Artemisinin Combination Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Artemisinin Combination Therapy Market Share by Region (2019-2024)
Table 13. Global Artemisinin Combination Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Artemisinin Combination Therapy Market Share by Region (2025-2030)
Table 15. Artemisinin Combination Therapy Market Trends
Table 16. Artemisinin Combination Therapy Market Drivers
Table 17. Artemisinin Combination Therapy Market Challenges
Table 18. Artemisinin Combination Therapy Market Restraints
Table 19. Global Artemisinin Combination Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global Artemisinin Combination Therapy Revenue Share by Players (2019-2024)
Table 21. Global Top Artemisinin Combination Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artemisinin Combination Therapy as of 2023)
Table 22. Global Artemisinin Combination Therapy Industry Ranking 2022 VS 2023 VS 2024
Table 23. Global 5 Largest Players Market Share by Artemisinin Combination Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 24. Global Key Players of Artemisinin Combination Therapy, Headquarters and Area Served
Table 25. Global Key Players of Artemisinin Combination Therapy, Product and Application
Table 26. Global Key Players of Artemisinin Combination Therapy, Product and Application
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Artemisinin Combination Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global Artemisinin Combination Therapy Revenue Market Share by Type (2019-2024)
Table 30. Global Artemisinin Combination Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global Artemisinin Combination Therapy Revenue Market Share by Type (2025-2030)
Table 32. Global Artemisinin Combination Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global Artemisinin Combination Therapy Revenue Share by Application (2019-2024)
Table 34. Global Artemisinin Combination Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global Artemisinin Combination Therapy Revenue Share by Application (2025-2030)
Table 36. North America Artemisinin Combination Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 37. North America Artemisinin Combination Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 38. North America Artemisinin Combination Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 39. North America Artemisinin Combination Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 40. North America Artemisinin Combination Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. North America Artemisinin Combination Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 42. North America Artemisinin Combination Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 43. Europe Artemisinin Combination Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 44. Europe Artemisinin Combination Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 45. Europe Artemisinin Combination Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 46. Europe Artemisinin Combination Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 47. Europe Artemisinin Combination Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Europe Artemisinin Combination Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 49. Europe Artemisinin Combination Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 50. China Artemisinin Combination Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 51. China Artemisinin Combination Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 52. China Artemisinin Combination Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 53. China Artemisinin Combination Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 54. Asia Artemisinin Combination Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 55. Asia Artemisinin Combination Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 56. Asia Artemisinin Combination Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 57. Asia Artemisinin Combination Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 58. Asia Artemisinin Combination Therapy Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 59. Asia Artemisinin Combination Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 60. Asia Artemisinin Combination Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Artemisinin Combination Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Artemisinin Combination Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Artemisinin Combination Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Artemisinin Combination Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Artemisinin Combination Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 66. Middle East, Africa, and Latin America Artemisinin Combination Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 67. Middle East, Africa, and Latin America Artemisinin Combination Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 68. KPC Pharmaceuticals Company Details
Table 69. KPC Pharmaceuticals Business Overview
Table 70. KPC Pharmaceuticals Artemisinin Combination Therapy Product
Table 71. KPC Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2019-2024) & (US$ Million)
Table 72. KPC Pharmaceuticals Recent Developments
Table 73. Shanghai Fosun Pharmaceutical Industrial Development Company Details
Table 74. Shanghai Fosun Pharmaceutical Industrial Development Business Overview
Table 75. Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Product
Table 76. Shanghai Fosun Pharmaceutical Industrial Development Revenue in Artemisinin Combination Therapy Business (2019-2024) & (US$ Million)
Table 77. Shanghai Fosun Pharmaceutical Industrial Development Recent Developments
Table 78. Sanofi Company Details
Table 79. Sanofi Business Overview
Table 80. Sanofi Artemisinin Combination Therapy Product
Table 81. Sanofi Revenue in Artemisinin Combination Therapy Business (2019-2024) & (US$ Million)
Table 82. Sanofi Recent Developments
Table 83. Desano Holdings Company Details
Table 84. Desano Holdings Business Overview
Table 85. Desano Holdings Artemisinin Combination Therapy Product
Table 86. Desano Holdings Revenue in Artemisinin Combination Therapy Business (2019-2024) & (US$ Million)
Table 87. Desano Holdings Recent Developments
Table 88. Calyx Chemicals and Pharmaceuticals Company Details
Table 89. Calyx Chemicals and Pharmaceuticals Business Overview
Table 90. Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Product
Table 91. Calyx Chemicals and Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2019-2024) & (US$ Million)
Table 92. Calyx Chemicals and Pharmaceuticals Recent Developments
Table 93. Mylan Company Details
Table 94. Mylan Business Overview
Table 95. Mylan Artemisinin Combination Therapy Product
Table 96. Mylan Revenue in Artemisinin Combination Therapy Business (2019-2024) & (US$ Million)
Table 97. Mylan Recent Developments
Table 98. Novartis Company Details
Table 99. Novartis Business Overview
Table 100. Novartis Artemisinin Combination Therapy Product
Table 101. Novartis Revenue in Artemisinin Combination Therapy Business (2019-2024) & (US$ Million)
Table 102. Novartis Recent Developments
Table 103. Denk Pharma Company Details
Table 104. Denk Pharma Business Overview
Table 105. Denk Pharma Artemisinin Combination Therapy Product
Table 106. Denk Pharma Revenue in Artemisinin Combination Therapy Business (2019-2024) & (US$ Million)
Table 107. Denk Pharma Recent Developments
Table 108. Hovid Berhad Company Details
Table 109. Hovid Berhad Business Overview
Table 110. Hovid Berhad Artemisinin Combination Therapy Product
Table 111. Hovid Berhad Revenue in Artemisinin Combination Therapy Business (2019-2024) & (US$ Million)
Table 112. Hovid Berhad Recent Developments
Table 113. Ipca Laboratories Company Details
Table 114. Ipca Laboratories Business Overview
Table 115. Ipca Laboratories Artemisinin Combination Therapy Product
Table 116. Ipca Laboratories Revenue in Artemisinin Combination Therapy Business (2019-2024) & (US$ Million)
Table 117. Ipca Laboratories Recent Developments
Table 118. Cipla Company Details
Table 119. Cipla Business Overview
Table 120. Cipla Artemisinin Combination Therapy Product
Table 121. Cipla Revenue in Artemisinin Combination Therapy Business (2019-2024) & (US$ Million)
Table 122. Cipla Recent Developments
Table 123. Aspen Pharmacare Holdings Company Details
Table 124. Aspen Pharmacare Holdings Business Overview
Table 125. Aspen Pharmacare Holdings Artemisinin Combination Therapy Product
Table 126. Aspen Pharmacare Holdings Revenue in Artemisinin Combination Therapy Business (2019-2024) & (US$ Million)
Table 127. Aspen Pharmacare Holdings Recent Developments
Table 128. Ajanta Pharma Company Details
Table 129. Ajanta Pharma Business Overview
Table 130. Ajanta Pharma Artemisinin Combination Therapy Product
Table 131. Ajanta Pharma Revenue in Artemisinin Combination Therapy Business (2019-2024) & (US$ Million)
Table 132. Ajanta Pharma Recent Developments
Table 133. Guilin Pharmaceuticals Company Details
Table 134. Guilin Pharmaceuticals Business Overview
Table 135. Guilin Pharmaceuticals Artemisinin Combination Therapy Product
Table 136. Guilin Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2019-2024) & (US$ Million)
Table 137. Guilin Pharmaceuticals Recent Developments
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Artemisinin Combination Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Artemisinin Combination Therapy Market Share by Type: 2023 VS 2030
Figure 3. Artemether+Lumefantrine Features
Figure 4. Artesunate+Amodiaquine Features
Figure 5. Dihydroartemisinin+Piperaquine Features
Figure 6. Artesunate+Mefloquine Features
Figure 7. Artesunate+Sulfadoxine-Pyrimethamine Features
Figure 8. Pyronaridine-Artesunate Features
Figure 9. Other Features
Figure 10. Global Artemisinin Combination Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 11. Global Artemisinin Combination Therapy Market Share by Application: 2023 VS 2030
Figure 12. Hospital Case Studies
Figure 13. Clinic Case Studies
Figure 14. Other Case Studies
Figure 15. Artemisinin Combination Therapy Report Years Considered
Figure 16. Global Artemisinin Combination Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Artemisinin Combination Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Artemisinin Combination Therapy Market Share by Region: 2023 VS 2030
Figure 19. Global Artemisinin Combination Therapy Market Share by Players in 2023
Figure 20. Global Top Artemisinin Combination Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artemisinin Combination Therapy as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Artemisinin Combination Therapy Revenue in 2023
Figure 22. North America Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Artemisinin Combination Therapy Market Share by Type (2019-2030)
Figure 24. North America Artemisinin Combination Therapy Market Share by Application (2019-2030)
Figure 25. North America Artemisinin Combination Therapy Market Share by Country (2019-2030)
Figure 26. United States Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Canada Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Artemisinin Combination Therapy Market Size YoY (2019-2030) & (US$ Million)
Figure 29. Europe Artemisinin Combination Therapy Market Share by Type (2019-2030)
Figure 30. Europe Artemisinin Combination Therapy Market Share by Application (2019-2030)
Figure 31. Europe Artemisinin Combination Therapy Market Share by Country (2019-2030)
Figure 32. Germany Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. France Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. U.K. Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Italy Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Russia Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Nordic Countries Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. China Artemisinin Combination Therapy Market Size YoY (2019-2030) & (US$ Million)
Figure 39. China Artemisinin Combination Therapy Market Share by Type (2019-2030)
Figure 40. China Artemisinin Combination Therapy Market Share by Application (2019-2030)
Figure 41. Asia Artemisinin Combination Therapy Market Size YoY (2019-2030) & (US$ Million)
Figure 42. Asia Artemisinin Combination Therapy Market Share by Type (2019-2030)
Figure 43. Asia Artemisinin Combination Therapy Market Share by Application (2019-2030)
Figure 44. Asia Artemisinin Combination Therapy Market Share by Region (2019-2030)
Figure 45. Japan Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. South Korea Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. China Taiwan Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. India Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Australia Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Artemisinin Combination Therapy Market Size YoY (2019-2030) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Artemisinin Combination Therapy Market Share by Type (2019-2030)
Figure 53. Middle East, Africa, and Latin America Artemisinin Combination Therapy Market Share by Application (2019-2030)
Figure 54. Middle East, Africa, and Latin America Artemisinin Combination Therapy Market Share by Country (2019-2030)
Figure 55. Brazil Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Mexico Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Turkey Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Saudi Arabia Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. Israel Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 60. GCC Countries Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 61. KPC Pharmaceuticals Revenue Growth Rate in Artemisinin Combination Therapy Business (2019-2024)
Figure 62. Shanghai Fosun Pharmaceutical Industrial Development Revenue Growth Rate in Artemisinin Combination Therapy Business (2019-2024)
Figure 63. Sanofi Revenue Growth Rate in Artemisinin Combination Therapy Business (2019-2024)
Figure 64. Desano Holdings Revenue Growth Rate in Artemisinin Combination Therapy Business (2019-2024)
Figure 65. Calyx Chemicals and Pharmaceuticals Revenue Growth Rate in Artemisinin Combination Therapy Business (2019-2024)
Figure 66. Mylan Revenue Growth Rate in Artemisinin Combination Therapy Business (2019-2024)
Figure 67. Novartis Revenue Growth Rate in Artemisinin Combination Therapy Business (2019-2024)
Figure 68. Denk Pharma Revenue Growth Rate in Artemisinin Combination Therapy Business (2019-2024)
Figure 69. Hovid Berhad Revenue Growth Rate in Artemisinin Combination Therapy Business (2019-2024)
Figure 70. Ipca Laboratories Revenue Growth Rate in Artemisinin Combination Therapy Business (2019-2024)
Figure 71. Cipla Revenue Growth Rate in Artemisinin Combination Therapy Business (2019-2024)
Figure 72. Aspen Pharmacare Holdings Revenue Growth Rate in Artemisinin Combination Therapy Business (2019-2024)
Figure 73. Ajanta Pharma Revenue Growth Rate in Artemisinin Combination Therapy Business (2019-2024)
Figure 74. Guilin Pharmaceuticals Revenue Growth Rate in Artemisinin Combination Therapy Business (2019-2024)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies